Intas Pharma launches affordable cancer drug - (Business Standard via NewsPoints Desk)

  • Intas Pharmaceuticals said that it is introducing a generic version of the cancer therapy azacitidine at one-fifth of the price of the branded formulation, Business Standard reported Wednesday.
  • The therapy will be marketed for the treatment of myelodysplastic syndrome and acute myelogenous leukaemia.
  • Intas will manufacture the drug at its facility in Ahmedabad, Gujarat.

To read more NewsPoints articles, click here.

Reference Articles